| Year |
Citation |
Score |
| 2023 |
Seyedsadr M, Wang Y, Elzoheiry M, Shree Gopal S, Jang S, Duran G, Chervoneva I, Kasimoglou E, Wrobel JA, Hwang D, Garifallou J, Zhang X, Khan TH, Lorenz U, Su M, ... ... Markovic-Plese S, et al. IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system. Proceedings of the National Academy of Sciences of the United States of America. 120: e2221007120. PMID 37339207 DOI: 10.1073/pnas.2221007120 |
0.35 |
|
| 2022 |
Kiapour N, Wu B, Wang Y, Seyedsadr M, Kapoor S, Zhang X, Elzoheiry M, Kasimoglu E, Wan Y, Markovic-Plese S. Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 35750335 DOI: 10.4049/jimmunol.2100176 |
0.444 |
|
| 2022 |
Montes M, Zhang X, Berthelot L, Laplaud DA, Brouard S, Jin J, Rogan S, Armao D, Jewells V, Soulillou JP, Markovic-Plese S. Corrigendum to "Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells" [Clinical Immunology 130 (2009) 133-144]. Clinical Immunology (Orlando, Fla.). 108967. PMID 35307286 DOI: 10.1016/j.clim.2022.108967 |
0.306 |
|
| 2021 |
Johnson BM, Uchimura T, Gallovic MD, Thamilarasan M, Chou WC, Gibson SA, Deng M, Tam JW, Batty CJ, Williams J, Matsushima GK, Bachelder EM, Ainslie KM, Markovic-Plese S, Ting JP. STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways. Journal of Immunology (Baltimore, Md. : 1950). PMID 33820855 DOI: 10.4049/jimmunol.2001317 |
0.331 |
|
| 2019 |
Zhang X, Kiapour N, Kapoor S, Khan T, Thamilarasan M, Tao Y, Cohen S, Miller R, Sobel RA, Markovic-Plese S. IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). PMID 31341075 DOI: 10.4049/Jimmunol.1900311 |
0.487 |
|
| 2018 |
Zhang X, Kiapour N, Kapoor S, Merrill JR, Xia Y, Ban W, Cohen SM, Midkiff BR, Jewells V, Shih YI, Markovic-Plese S. IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis. Clinical Immunology (Orlando, Fla.). PMID 30149119 DOI: 10.1016/J.Clim.2018.08.006 |
0.45 |
|
| 2016 |
Sha Y, Markovic-Plese S. Activated IL-1RI Signaling Pathway Induces Th17 Cell Differentiation via Interferon Regulatory Factor 4 Signaling in Patients with Relapsing-Remitting Multiple Sclerosis. Frontiers in Immunology. 7: 543. PMID 27965670 DOI: 10.3389/Fimmu.2016.00543 |
0.463 |
|
| 2016 |
Tao Y, Zhang X, Markovic-Plese S. Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS). Journal of Neuroimmunology. 298: 181-8. PMID 27609294 DOI: 10.1016/J.Jneuroim.2016.07.019 |
0.373 |
|
| 2015 |
Tao Y, Zhang X, Zivadinov R, Dwyer MG, Kennedy C, Bergsland N, Ramasamy D, Durfee J, Hojnacki D, Hayward B, Dangond F, Weinstock-Guttman B, Markovic-Plese S. Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS. Neurology(R) Neuroimmunology & Neuroinflammation. 2: e176. PMID 26601116 DOI: 10.1212/Nxi.0000000000000176 |
0.527 |
|
| 2015 |
Dwyer MG, Zivadinov R, Tao Y, Zhang X, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Weinstock-Guttman B, Hayward B, Dangond F, Markovic-Plese S. Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial. Bmc Neurology. 15: 232. PMID 26559139 DOI: 10.1186/S12883-015-0488-9 |
0.35 |
|
| 2015 |
Zhang X, Putoczki T, Markovic-Plese S. IL-11 in multiple sclerosis. Oncotarget. 6: 32297-8. PMID 26452137 DOI: 10.18632/Oncotarget.6027 |
0.444 |
|
| 2015 |
Zhang X, Tao Y, Chopra M, Dujmovic-Basuroski I, Jin J, Tang Y, Drulovic J, Markovic-Plese S. IL-11 Induces Th17 Cell Responses in Patients with Early Relapsing-Remitting Multiple Sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 194: 5139-49. PMID 25895532 DOI: 10.4049/Jimmunol.1401680 |
0.516 |
|
| 2015 |
Dwyer MG, Zivadinov R, Markovic-Plese S, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Weinstock-Guttman B, Hayward B, Dangond F. Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weekly. Journal of Neuroimmunology. 281: 44-50. PMID 25867467 DOI: 10.1016/J.Jneuroim.2015.03.002 |
0.302 |
|
| 2015 |
Blauth K, Zhang X, Chopra M, Rogan S, Markovic-Plese S. The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis. Clinical Immunology (Orlando, Fla.). 157: 121-32. PMID 25596452 DOI: 10.1016/J.Clim.2015.01.001 |
0.645 |
|
| 2014 |
Tao Y, Zhang X, Chopra M, Kim MJ, Buch KR, Kong D, Jin J, Tang Y, Zhu H, Jewells V, Markovic-Plese S. The role of endogenous IFN-β in the regulation of Th17 responses in patients with relapsing-remitting multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 192: 5610-7. PMID 24850724 DOI: 10.4049/Jimmunol.1302580 |
0.48 |
|
| 2014 |
Zivadinov R, Dwyer MG, Markovic-Plese S, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Hayward B, Dangond F, Weinstock-Guttman B. Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study. Plos One. 9: e91098. PMID 24625687 DOI: 10.1371/Journal.Pone.0091098 |
0.339 |
|
| 2013 |
Freedman MS, Kaplan JM, Markovic-Plese S. Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis. Journal of Clinical & Cellular Immunology. 4. PMID 24363961 DOI: 10.4172/2155-9899.1000152 |
0.496 |
|
| 2013 |
Zhang X, Tao Y, Chopra M, Ahn M, Marcus KL, Choudhary N, Zhu H, Markovic-Plese S. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 191: 5867-74. PMID 24198283 DOI: 10.4049/Jimmunol.1301926 |
0.539 |
|
| 2013 |
Zhang X, Tao Y, Wang J, Garcia-Mata R, Markovic-Plese S. Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis European Journal of Immunology. 43: 281-289. PMID 23076801 DOI: 10.1002/Eji.201242566 |
0.487 |
|
| 2013 |
Li Y, Jewells V, Kim M, Chen Y, Moon A, Armao D, Troiani L, Markovic-Plese S, Lin W, Shen D. Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis. Human Brain Mapping. 34: 3376-91. PMID 22987661 DOI: 10.1002/Hbm.22158 |
0.326 |
|
| 2012 |
Brück W, Popescu B, Lucchinetti CF, Markovic-Plese S, Gold R, Thal DR, Metz I. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate. Annals of Neurology. 72: 385-94. PMID 23034911 DOI: 10.1002/Ana.23621 |
0.354 |
|
| 2012 |
Broux B, Markovic-Plese S, Stinissen P, Hellings N. Pathogenic features of CD4+CD28- T cells in immune disorders. Trends in Molecular Medicine. 18: 446-53. PMID 22784556 DOI: 10.1016/J.Molmed.2012.06.003 |
0.46 |
|
| 2012 |
Broux B, Pannemans K, Zhang X, Markovic-Plese S, Broekmans T, Eijnde BO, Van Wijmeersch B, Somers V, Geusens P, van der Pol S, van Horssen J, Stinissen P, Hellings N. CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients. Journal of Autoimmunity. 38: 10-9. PMID 22123179 DOI: 10.1016/J.Jaut.2011.11.006 |
0.552 |
|
| 2012 |
Zhang X, Tao Y, Chopra M, Troiani L, Marcus K, Choudhary N, Wray S, Krolczyk S, Markovic-Plese S. Alemtuzumab (Anti-CD52 mAb) Induces Expansion of Treg and Th2 Cells and Inhibits Th1 and Th17 Cells in Treated Patients with Relapsing Remitting Multiple Sclerosis (RRMS) (P02.119) Neurology. 78: P02.119-P02.119. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.119 |
0.476 |
|
| 2011 |
Ramgolam VS, Markovic-Plese S. Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosis. Journal of Signal Transduction. 2011: 635721. PMID 22132325 DOI: 10.1155/2011/635721 |
0.482 |
|
| 2011 |
Zhang X, Tao Y, Troiani L, Markovic-Plese S. Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 187: 3431-7. PMID 21856936 DOI: 10.4049/Jimmunol.1100580 |
0.493 |
|
| 2011 |
Meeker RB, Poulton W, Markovic-Plese S, Hall C, Robertson K. Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection. Journal of Neurovirology. 17: 258-73. PMID 21556959 DOI: 10.1007/S13365-011-0034-5 |
0.301 |
|
| 2011 |
Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S. B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 186: 4518-26. PMID 21368231 DOI: 10.4049/Jimmunol.1000271 |
0.434 |
|
| 2010 |
Ramgolam VS, DeGregorio SD, Rao GK, Collinge M, Subaran SS, Markovic-Plese S, Pardi R, Bender JR. T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascade. Plos One. 5: e14450. PMID 21206905 DOI: 10.1371/Journal.Pone.0014450 |
0.392 |
|
| 2010 |
Zhang X, Markovic-Plese S. Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis. Clinical Neurology and Neurosurgery. 112: 641-5. PMID 20570038 DOI: 10.1016/J.Clineuro.2010.04.020 |
0.467 |
|
| 2010 |
Ramgolam VS, Markovic-Plese S. Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosis. Endocrine, Metabolic & Immune Disorders Drug Targets. 10: 161-7. PMID 20384573 DOI: 10.2174/187153010791213029 |
0.508 |
|
| 2009 |
Ramgolam VS, Sha Y, Jin J, Zhang X, Markovic-Plese S. IFN-beta inhibits human Th17 cell differentiation. Journal of Immunology (Baltimore, Md. : 1950). 183: 5418-27. PMID 19783688 DOI: 10.4049/Jimmunol.0803227 |
0.438 |
|
| 2009 |
Markovic-Plese S. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 15: 225-31. PMID 19297658 DOI: 10.1177/1073858409332404 |
0.466 |
|
| 2009 |
Zhang X, Jin J, Tang Y, Speer D, Sujkowska D, Markovic-Plese S. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. Journal of Immunology (Baltimore, Md. : 1950). 182: 3928-36. PMID 19265172 DOI: 10.4049/Jimmunol.0802226 |
0.429 |
|
| 2009 |
Montes M, Zhang X, Berthelot L, Laplaud DA, Brouard S, Jin J, Rogan S, Armao D, Jewells V, Soulillou JP, Markovic-Plese S. Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clinical Immunology (Orlando, Fla.). 130: 133-44. PMID 18977698 DOI: 10.1016/J.Clim.2008.08.030 |
0.485 |
|
| 2008 |
Markovic-Plese S, Singh AK, Singh I. Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair. Future Neurology. 3: 153. PMID 20107624 DOI: 10.2217/14796708.3.2.153 |
0.37 |
|
| 2008 |
Lindzen E, Jewells V, Bouldin T, Speer D, Royal W, Markovic-Plese S. Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy. Journal of Neurovirology. 14: 569-73. PMID 19021074 DOI: 10.1080/13550280802304753 |
0.388 |
|
| 2008 |
Zhang X, Markovic-Plese S. Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response. Immunologic Research. 41: 165-74. PMID 18484192 DOI: 10.1007/S12026-008-8019-Z |
0.515 |
|
| 2008 |
Zhang X, Jin J, Peng X, Ramgolam VS, Markovic-Plese S. Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 180: 6988-96. PMID 18453621 DOI: 10.4049/Jimmunol.180.10.6988 |
0.468 |
|
| 2008 |
Zhang X, Tang Y, Sujkowska D, Wang J, Ramgolam V, Sospedra M, Adams J, Martin R, Pinilla C, Markovic-Plese S. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis. European Journal of Immunology. 38: 1297-309. PMID 18412170 DOI: 10.1002/Eji.200737519 |
0.466 |
|
| 2006 |
Peng X, Jin J, Giri S, Montes M, Sujkowski D, Tang Y, Smrtka J, Vollmer T, Singh I, Markovic-Plese S. Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis. Journal of Neuroimmunology. 178: 130-9. PMID 16870268 DOI: 10.1016/J.Jneuroim.2006.06.005 |
0.485 |
|
| 2005 |
Markovic-Plese S, Hemmer B, Zhao Y, Simon R, Pinilla C, Martin R. High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: implications for the initiation of autoimmune response in multiple sclerosis. Journal of Neuroimmunology. 169: 31-8. PMID 16150497 DOI: 10.1016/J.Jneuroim.2005.07.014 |
0.428 |
|
| 2004 |
Markovic-Plese S, Pinilla C, Martin R. The initiation of the autoimmune response in multiple sclerosis. Clinical Neurology and Neurosurgery. 106: 218-22. PMID 15177771 DOI: 10.1016/J.Clineuro.2004.02.018 |
0.462 |
|
| 2004 |
Bielekova B, Richert N, Howard T, Blevins G, Markovic-Plese S, McCartin J, Frank JA, Würfel J, Ohayon J, Waldmann TA, McFarland HF, Martin R. Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proceedings of the National Academy of Sciences of the United States of America. 101: 8705-8. PMID 15161974 DOI: 10.1073/Pnas.0402653101 |
0.448 |
|
| 2004 |
Vollmer T, Key L, Durkalski V, Tyor W, Corboy J, Markovic-Plese S, Preiningerova J, Rizzo M, Singh I. Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet (London, England). 363: 1607-8. PMID 15145635 DOI: 10.1016/S0140-6736(04)16205-3 |
0.337 |
|
| 2004 |
Bielekova B, Richert N, Howard T, Blevins G, Markovic-Plese S, McCartin J, Frank JA, Würfel J, Ohayon J, Waldmann TA, McFarland HF, Martin R. Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708)) Proceedings of the National Academy of Sciences of the United States of America. 101. DOI: 10.1073/Pnas.0404694101 |
0.399 |
|
| 2003 |
Markovic-Plese S, Bielekova B, Kadom N, Leist TP, Martin R, Frank JA, McFarland HF. Longitudinal MRI study: the effects of azathioprine in MS patients refractory to interferon beta-1b. Neurology. 60: 1849-51. PMID 12796549 DOI: 10.1212/01.Wnl.0000071218.34009.Af |
0.362 |
|
| 2001 |
Markovic-Plese S, McFarland HF. Immunopathogenesis of the multiple sclerosis lesion. Current Neurology and Neuroscience Reports. 1: 257-62. PMID 11898527 DOI: 10.1007/S11910-001-0028-4 |
0.406 |
|
| 2001 |
Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R. CD4+CD28- costimulation-independent T cells in multiple sclerosis. The Journal of Clinical Investigation. 108: 1185-94. PMID 11602626 DOI: 10.1172/Jci12516 |
0.525 |
|
| 2001 |
Kondo T, Cortese I, Markovic-Plese S, Wandinger KP, Carter C, Brown M, Leitman S, Martin R. Dendritic cells signal T cells in the absence of exogenous antigen Nature Immunology. 2: 932-938. PMID 11561182 DOI: 10.1038/Ni711 |
0.46 |
|
| 2001 |
Zhao Y, Gran B, Pinilla C, Markovic-Plese S, Hemmer B, Tzou A, Whitney LW, Biddison WE, Martin R, Simon R. Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands Journal of Immunology. 167: 2130-2141. PMID 11489997 DOI: 10.4049/Jimmunol.167.4.2130 |
0.326 |
|
| 2001 |
Martin R, Gran B, Zhao Y, Markovic-Plese S, Bielekova B, Marques A, Sung MH, Hemmer B, Simon R, McFarland HF, Pinilla C. Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease. Journal of Autoimmunity. 16: 187-92. PMID 11334482 DOI: 10.1006/Jaut.2000.0501 |
0.432 |
|
| 2000 |
Arndt SO, Vogt AB, Markovic-Plese S, Martin R, Moldenhauer G, Wölpl A, Sun Y, Schadendorf D, Hämmerling GJ, Kropshofer H. Functional HLA-DM on the surface of B cells and immature dendritic cells Embo Journal. 19: 1241-1251. PMID 10716924 DOI: 10.1093/Emboj/19.6.1241 |
0.343 |
|
| 2000 |
Markovic-Plese S. Molecular mimicry in neurological diseases Neuroscientist. 6: 428-432. DOI: 10.1177/107385840000600605 |
0.41 |
|
| 1994 |
Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. The Journal of Experimental Medicine. 179: 973-84. PMID 7509366 DOI: 10.1084/Jem.179.3.973 |
0.517 |
|
| 1994 |
Markovic-Plese S, Fukoara H, Al-Sabbagh A, Sette A, Kuchroo VK, Hafler DA. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans Journal of Neuroimmunology. 54: 179. DOI: 10.1016/0165-5728(94)90423-5 |
0.361 |
|
| Show low-probability matches. |